JW (Cayman) Therapeutics Co. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG5210T1040
HKD
3.05
0.04 (1.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
192.11
169.43
37.12
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
192.11
169.43
37.12
0.00
0.00
0.00
Raw Material Cost
177.34
173.53
74.49
26.51
19.62
6.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
339.28
431.83
409.47
175.66
105.65
42.06
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.72
7.89
3.24
0.87
1.53
3.46
Selling and Distribution Expenses
266.42
416.83
438.85
231.76
79.98
48.46
Other Expenses
3.48
-2.37
4.82
5.31
3.02
3.89
Total Expenditure (Excl Depreciation)
831.51
1,006.36
974.29
487.92
236.99
138.87
Operating Profit (PBDIT) excl Other Income
-639.4
-836.9
-937.2
-487.9
-237
-138.9
Other Income
4.72
-139.13
34.84
45.26
6.96
7.23
Operating Profit (PBDIT)
-526.83
-877.44
-851.62
-416.16
-210.41
-125.59
Interest
13.72
7.89
3.24
0.87
1.53
3.46
Exceptional Items
-200.23
0.00
59.13
-1,426.08
-486.50
-187.81
Gross Profit (PBDT)
14.77
-4.10
-37.38
-26.51
-19.62
-6.05
Depreciation
107.85
98.62
50.72
26.51
19.62
6.05
Profit Before Tax
-848.63
-983.95
-846.45
-1,869.60
-718.06
-322.90
Tax
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-848.63
-983.95
-846.45
-1,869.60
-718.06
-322.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-848.63
-983.95
-846.45
-1,869.60
-718.06
-322.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-848.63
-983.95
-846.45
-1,869.60
-718.06
-322.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,853.91
2,643.25
3,413.96
4,066.43
-1,054.10
-357.16
Earnings per share (EPS)
-2.06
-2.4
-2.12
-4.96
-1.9
-0.86
Diluted Earnings per share
-2.06
-2.4
-2.12
-4.96
-1.9
-0.86
Operating Profit Margin (Excl OI)
-332.83%
-493.95%
-2524.93%
0.0%
0.0%
0.0%
Gross Profit Margin
-385.6%
-522.52%
-2143.85%
0.0%
0.0%
0.0%
PAT Margin
-441.74%
-580.73%
-2280.51%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is 13.40% vs 356.60% in Dec 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is 13.76% vs -16.24% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is 28.01% vs 16.72% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is 73.42% vs 146.88% in Dec 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has improved from Dec 2022

Compare Annual Results Of JW (Cayman) Therapeutics Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
192.11
0.00
192.11
Other Operating Income
0.00
0.00
0.00
Total Operating income
192.11
0.00
192.11
Raw Material Cost
177.34
67.63
109.71
162.22%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
339.28
184.80
154.48
83.59%
Power Cost
0
0
0.00
Manufacturing Expenses
13.72
10.71
3.01
28.10%
Selling and Distribution Expenses
266.42
95.98
170.44
177.58%
Other Expenses
3.48
83.12
-79.64
-95.81%
Total Expenditure (Excl Depreciation)
831.51
1,190.27
-358.76
-30.14%
Operating Profit (PBDIT) excl Other Income
-639.40
-1,190.27
550.87
46.28%
Other Income
4.72
19.83
-15.11
-76.20%
Operating Profit (PBDIT)
-526.83
-1,149.47
622.64
54.17%
Interest
13.72
10.71
3.01
28.10%
Exceptional Items
-200.23
0.00
-200.23
Gross Profit (PBDT)
14.77
-67.63
82.40
121.84%
Depreciation
107.85
20.97
86.88
414.31%
Profit Before Tax
-848.63
-1,181.15
332.52
28.15%
Tax
0.00
-8.89
8.89
100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-848.63
-1,172.20
323.57
27.60%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-848.63
-1,172.20
323.57
27.60%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-848.63
-1,172.20
323.57
27.60%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,853.91
504.38
1,349.53
267.56%
Earnings per share (EPS)
-2.06
-2.73
0.67
24.54%
Diluted Earnings per share
-2.06
-2.73
0.67
24.54%
Operating Profit Margin (Excl OI)
-332.83%
0.00%
0.00
-332.83%
Gross Profit Margin
-385.60%
0.00%
0.00
-385.60%
PAT Margin
-441.74%
0.00%
0.00
-441.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 19.21 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 13.40% vs 356.60% in Dec 2022

Annual - Consolidate Net Profit
Consolidate Net Profit -84.86 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 13.76% vs -16.24% in Dec 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -53.15 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 28.01% vs 16.72% in Dec 2022

Annual - Interest
Interest 1.37 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 73.42% vs 146.88% in Dec 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -332.83%
in Dec 2023

Figures in %
stock-summary

YoY Growth in year ended Dec 2023 has improved from Dec 2022